Inventor · disambiguated record
Kerstin Menander
Also filed as: MENANDER KERSTIN · MENANDER KERSTIN B
12 granted patents·15 pending applications·179 citations·filing 1998–2021
91Inventor score
Files withCELL PATHWAYS INC6MULTIVIR INC6INTROGEN THERAPEUTICS INC4ANTONIA SCOTT1NORTHSHORE UNIV HEALTH SYSTEM1
Top patents by PatentIndex Score
27 records- 0190US6235782B1Method for treating a patient with neoplasia by treatment with a platinum coordination complexFiled 1998·Granted May 22, 2001·65 cites·10 claims
- 0283US6177471B1Method for treating patients with acne by administering a CGMP-specific PDE inhibitorCELL PATHWAYS INC·Filed 1999·Granted Jan 23, 2001·66 cites·1 claims
- 0379US8668905B2P53 vaccines for the treatment of cancersANTONIA SCOTT·Filed 2006·Granted Mar 11, 2014·3 cites·35 claims
- 0477US6359002B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexCELL PATHWAYS INC·Filed 2001·Granted Mar 19, 2002·4 cites·1 claims
- 0575US9746471B2P53 biomarkersSOBOL ROBERT E·Filed 2009·Granted Aug 29, 2017·2 cites·10 claims
- 0675US6869944B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexOSI PHARM INC·Filed 2002·Granted Mar 22, 2005·3 cites·3 claims
- 0770US6365627B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2001·Granted Apr 2, 2002·1 cites·1 claims
- 0869US6472420B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2002·Granted Oct 29, 2002·1 cites·3 claims
- 0960US6025394AMethod for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcoholsCELL PATHWAYS INC·Filed 1999·Granted Feb 15, 2000·22 cites·9 claims
- 1060US2015044240A1P53 vaccines for the treatment of cancersUNIV SOUTH FLORIDA·Filed 2014·Application pending·0 cites
- 1159US12454561B2Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancerMULTIVIR INC·Filed 2019·Granted Oct 28, 2025·0 cites·23 claims
- 1259US10883993B2P53 biomarkersMULTIVIR INC·Filed 2017·Granted Jan 5, 2021·0 cites·12 claims
- 1359US6235776B1Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 1998·Granted May 22, 2001·12 cites·10 claims
- 1457US2021090124A1P53 biomarkersMULTIVIR INC·Filed 2020·Application pending·0 cites
- 1557US2003220252A1Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analogFiled 2003·Application pending·0 cites
- 1655US2002193286A1Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analogFiled 2002·Application pending·0 cites
- 1754US2007231304A1Prognostic factors for anti-hyperproliferative disease gene therapyINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1852US2002091157A1Method for treating a patient with neoplasla by treatment with a platinum coordination complexFiled 2002·Application pending·0 cites
- 1949US2024042061A1Methods and compositions comprising tumor suppressor gene therapy for the inhibition of pathogensMULTIVIR INC·Filed 2021·Application pending·0 cites
- 2046US2002022586A1Method for treating a patient with neoplasia by treatment with a pyrimidine analogFiled 2000·Application pending·0 cites
- 2144US2006153808A1Cancer immunotherapy incorporating p53INTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2244US2022226402A1Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancerNORTHSHORE UNIV HEALTH SYSTEM·Filed 2020·Application pending·0 cites
- 2342US2007066552A1Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acidsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2442US2003130210A1Method for treating a patient with neoplasia by treatment with an anthracycline antibioticFiled 2002·Application pending·0 cites
- 2541US2008293652A1Combination of Ad-P53 and Chemotherapy for the Treatment of TumoursINTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2638US2020009203A1Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseasesMULTIVIR INC·Filed 2017·Application pending·0 cites
- 2736US2019038713A1Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancerMULTIVIR INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kerstin Menander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →